Background
==========

Neuronal hypersensitivity is a hallmark feature of neuropathic pain. The ATP-gated ionotropic P2X3 receptor \[[@B1],[@B2]\] has been demonstrated to play significant roles in neuronal hyperexcitability and neuropathic pain in damaged sensory neurons \[[@B3]-[@B6]\]. To date, however, there is no clear understanding of how the P2X3 receptor influences neuronal hypersensitivity under neuropathic pain conditions. If the P2X3 receptor contributes directly to neuronal hypersensitivity, one might expect an upregulation of its function after nerve damage. Consistent with this hypothesis, some studies have described increased P2X3 expression following nerve injury \[[@B7],[@B8]\]. However, others have reported evidence of decreased P2X3 expression in neuropathic conditions \[[@B9]\] with lowered or unchanged level of P2X receptor function in subsets of dorsal root ganglion (DRG) neurons \[[@B10]\]. Indeed, while ATP evokes strong responses from neuropathic sensory neurons, it is not clear whether this is a direct effect of increased P2X3 currents, or an indirect effect reflecting increased intrinsic neuronal excitability.

Numerous reports have demonstrated an association between neuropathic injuries and changes in the expression of voltage-gated sodium channels (VGSC) \[[@B11]\]. One of the most dramatic VGSC alterations after neuropathic injury is the upregulation of the embryonic Na~v~1.3 α subunit \[[@B12]\]. The Na~v~1.3 α subunit is highly expressed in embryonic DRG neurons, but is developmentally regulated such that it is only weakly expressed in adult DRG neurons \[[@B13]\]. Regulation of gene expression is not the only mechanism known to modulate VGSC function in neurons. Changes in phosphorylation states mediated by serine/threonine protein kinases have been shown to directly affect functional properties of Na~v~1.2 \[[@B14]\], Na~v~1.7 and Na~v~1.8 \[[@B15],[@B16]\]. Involvement of serine/threonine protein kinases, especially protein kinase C (PKC), in neuropathic pain has been clearly demonstrated \[[@B17],[@B18]\]. However, a modulatory role of PKC on the Na~v~1.3 subunit has yet to be determined.

The aim of the present study is to understand how P2X3 receptors and Na~v~1.3 VGSCs contribute to neuronal hyperexcitability in neuropathic DRG neurons. Here we report that upregulation of Na~v~1.3 increases intrinsic neuronal excitability, whereas ATP-gated currents through P2X3 receptors contribute sufficient depolarization to elicit spikes in damaged DRG neurons. We also show that PKC modulates neuronal hyperexcitability by regulating the function of Na~v~1.3. These data provide new insights into how injured peripheral nociceptors mediate abnormal ectopic firing that could sustain neuropathic pain.

Materials and methods
=====================

Neuropathic model
-----------------

This study was conducted under a protocol that has been approved by an ethical committee. The animals were kept and experiments were performed at AstraZeneca R&D Montréal which has accreditation from CCAC (Canadian Council on Animal Care), AAALAC (Association for the Assessment and Accreditation of Laboratory Animal Care) and/or approved by AZ GVC (AstraZeneca Global Veterinary Council) for study conduct.

Spinal nerve ligations (SNL) at L5 and L6 levels were carried out in Sprague-Dawley male rats weighing 125-150 g following a protocol previously described by Kim and Chung \[[@B19]\]. In summary, after inducing deep anaesthesia using isoflurane inhalation, a 2 cm dorsal incision was made approximately from L3 and S2 vertebral regions. Paraspinal muscles on the left side were detached from the spinous processes in order to reveal the L5 and L6 spinal nerves. Once the nerves were cleared from connective tissue, a tight ligation was made on each nerve using a 4-0 silk thread. The muscles were then moved back to the appropriate regions along the vertebrae then the incision was sutured and antibiotic ointment was applied. During surgery the animals were given a constant flow of isoflurane inhalation to maintain deep anaesthesia.

Neuronal and non-neuronal cell culture
--------------------------------------

DRGs from lumbar segments L4-L6 were extracted from naïve male Sprague-Dawley rats weighing 340-400 g (Charles River Canada) under deep anaesthesia induced by isoflurane.

For the SNL conditions, L5 and L6 lumbar segment DRGs on the ipsilateral side of the ligation were harvested at 35-40 days post-injury under deep anaesthesia induced by isoflurane.

Extracted DRGs were placed in ice-cold oxygenated DMEM (Gibco) for removal of connective tissue and dura mater. The isolated DRGs were then placed into DMEM containing 1 mg/mL of papain and 2 mg/mL collagenase type II (Sigma-Aldrich) and incubated for 1 h at 37°C and 100% humidity. After enzymatic digestion, the DRGs were transferred into DMEM containing 10% FBS and 1% L-glutamine, dissociated into single neurons by means of trituration using fire-polished pipettes. Dissociated neurons were then plated onto 35 mm cell culture dishes (Sarstedt) coated with laminin (BD Bioscience) and poly-D-lysine (Sigma-Aldrich), and cultured for 48 h at 37°C and 100% humidity in F-12 media (Gibco) containing 10% FBS, 1% L-glutamine as well as 100 U/mL penicillin and streptomycin.

CHO cells stably expressing human Na~v~1.3 α subunit (cell line CNahIII-12, \[[@B20]\]) were cultured in IMDM supplemented with 10% fetal bovine serum, 1% sodium hypoxanthine and thymidine (HT) supplement, 1% MEM non-essential amino acids, 100 U/mL Penicillin and streptomycin, and 400 μg/mL G418 (Gibco).

Patch-clamp recordings in DRG neurons and CHO cells
---------------------------------------------------

Whole-cell patch-clamp recordings on DRG neurons were conducted using micropipettes produced by pulling borosilicate glass tubes using a P-97 puller (Sutter Instrument, Novato, CA), and fire-polishing with a MP-830 microforge (Narishige, Tokyo, Japan) to a tip resistance of 0.8-1 MΩ when filled with pipette solution, pH 7.2, containing (in mM): 140 CsCl, 10 NaCl, 1 EGTA and 5 HEPES. During recordings the neurons were constantly perfused with a solution at pH 7.4, comprised of (in mM): 98 choline-Cl, 42 NaCl, 3 KCl, 2 CaCl~2~, 2 MgCl~2~, 10 HEPES, 10 glucose, 25 TEA and 3 4-AP.

Membrane currents were recorded using an Axopatch 200B amplifier, digitized with a Digidata 3200A interface (Axon Instruments, Foster City, CA.), and acquired at a frequency of 5 kHz using pClamp 9. Voltage dependence of activation was determined from peak currents in response to 50 ms test pulses ranging from -80 to +90 mV.

Whole-cell patch-clamp recordings were also carried out in CHO cells stably expressing the Na~v~1.3 α subunit. The same voltage protocol was conducted using micropipettes with a tip resistance of 2-4 MΩ filled with a solution at pH 7.2, containing (in mM): 105 Cs-Asp, 10 CsCl, 10 NaCl, 5 EGTA and 10 HEPES. During recordings the cells were constantly perfused with an external solution at pH 7.4 containing (in mM): 130 NaCl, 4 KCl, 1.5 CaCl~2~, 1 MgCl~2~, 10 HEPES and 5 glucose. For CHO cell recordings, compensation for leak current was carried out using the P/4 protocol included in the pClamp 9 acquisition software. For all recordings the membrane capacitance (C~m~) and series resistance (R~s~) were measured through the peak amplitude and decay constant of transients induced by repetitive depolarizing pulses of 10 mV.

Tissue collection and preparation
---------------------------------

Adult male Sprague-Dawley rats (Charles River, Saint-Constant, Quebec, Canada) were euthanized by decapitation. Spinal cords with DRG attached were rapidly dissected, snap-frozen at -40°C in isopentane for 20 s and stored at -80°C. Frozen spinal cord tissue with DRGs attached were transversely cryosectioned at 14 μm and thaw-mounted onto Superfrost Plus slides (VWR, Montreal, Quebec, Canada). Slides were stored at -80°C until processing for *in situ*hybridization.

Na~V~1.3 riboprobe design and synthesis
---------------------------------------

A 409-base pair fragment spanning nt. 6325-6733 in the 3\'-untranslated region of the rat Na~v~1.3 gene (accession number NM_013119) was amplified in PCR from rat genomic DNA using 5\'-TATCCGTGTCAACTGGAC-3\' as the forward primer and 5\'-ACTTGTGGACTTAGCAAC-3\' as the reverse primer. PCR cycling (reaction mix: 1 ng of genomic DNA, 0.2 μM of each dNTP, 1 mM of each primer, 5 U of *Taq*DNA polymerase in 1 × *Taq*DNA polymerase buffer) was 3 min at 95°C, followed by 25 cycles of 30 s at 95°C, 45 s at 50°C and 30 s at 72°C. The amplicon was isolated on an agarose gel using the QIAquick gel extraction kit (Qiagen, Mississauga, Ontario, Canada) and was ligated into pGEM-T-Easy vector (Promega, Nepean, Ontario, Canada). Plasmid from a single clone was purified using HiSpeed Plasmid Midi kit (Qiagen). The Na~v~1.3 plasmid was linearized using NcoI and SpeI restriction enzymes (Promega). Antisense riboprobes were transcribed *in vitro*using SP6 RNA polymerase (Promega) and radiolabeled with ^35^S-UTP and ^35^S-CTP (800 Ci/mmol; Amersham Biosciences, Inc). Following transcription, the Na~v~1.3 DNA template was digested with DNAse I (Promega) and subsequently purified using G-50 Sepharose microspin columns (GE Healthcare). The quality of labeled riboprobes was verified by polyacrylamide-urea gel electrophoresis and scintillation counting.

In situ hybridization (ISH) and histological analysis
-----------------------------------------------------

ISH was performed on rat tissue sections as previously described (Ahmad et al 2007). Briefly, tissue sections were fixed with 4% paraformaldehyde, rinsed 3 times in 2 × standard sodium citrate buffer (2 × SSC), equilibrated in 0.1 M triethanolamine, and treated with 0.25% acetic anhydride in 0.1 M triethanolamine. After a rinse in 2 × SSC and dehydration through an ethanol series (50-100%), hybridization was performed in a buffer containing 75% formamide (Sigma), 600 mM NaCl, 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 × Denhardt\'s solution (Sigma), 50 μg/ml denatured salmon sperm DNA (Sigma), 10% dextran sulfate (Sigma), 20 mM dithiothreitol, and \[^35^S\]-labeled cRNA probe (20 × 106 cpm/ml) at 55°C overnight in chambers humidified with 75% formamide.

Following hybridization, slides were rinsed twice in 2 × SSC at room temperature, treated with 20 μg/ml RNase IA in RNase buffer (25 mM NaCl, 5 mM Tris-HCl pH 7.5, 0.5 mM EDTA pH 8.0) for 45 minutes at 37°C, and washed to a final stringency of 0.1 × SSC at 70°C. Sections were then dehydrated and exposed to Kodak Biomax MR-2 film. After exposed to film, the slides were dipped in Kodak NTB2 emulsion and exposed for 8 weeks at 4°C prior to development and counterstaining with hematoxylin and eosin.

Film autoradiograms were digitized with a high-resolution Xillix Microimager digital camera via the MCID image analysis system (Imaging Research, St-Catharines, Ontario, Canada). Bright- and darkfield photomicrographs of emulsion-dipped tissue sections were captured using a Leica (DMRBE/DM 4000B) microscope equipped with a Leica DFC490 digital camera. Digital images were transferred to Adobe Photoshop 7.0 for minimal image processing.

Statistical analysis
--------------------

Data are presented as mean ± S.E.M. All statistical analyses for the difference in means were carried out using unpaired as well as paired Student\'s *t*test and one-way ANOVA followed by Bonferroni\'s multiple comparison tests. Normalized data were analyzed using nonparametric Mann-Whitney U test.

Results
=======

Neuropathic vs Naïve Purinergic Response
----------------------------------------

The overall morphology of DRG neurons was indistinguishable between naïve and neuropathic conditions. Three distinct populations of neurons (small, medium and large diameter) were present in all cultures. For the purpose of this study, recordings were conducted only on small diameter DRG neurons nociceptors, based on cell body diameter of \<30 μm, with functional P2X3 receptors as determined by rapidly activating and fast desensitizing current kinetics in response to the selective agonist α,β-meATP. In DRG neurons from both control and neuropathic animals, application of 10 μM α,β-meATP resulted in inward current (Figure [1A, B](#F1){ref-type="fig"}); however, in the neuropathic DRGs, α,β-meATP elicited a large transient spike, which was not observed in control DRGs. We hypothesized that this large inward spike in neuropathic neurons might be caused by activation of VGSCs. In other words, in neuropathic conditions, a small initial depolarization caused by the inward current through P2X receptors and not completely compensated by the clamp might be sufficient to trigger a regenerative inward sodium spike. To test this hypothesis, we applied a saturating concentration of TTX (1 μM) and found that it selectively inhibited the inward spike, leaving the purinergic ionotropic response at levels similar to naïve neurons (Figure [1C, D](#F1){ref-type="fig"}). These data suggest that after neuropathic injury, small diameter DRG neurons express large TTX-sensitive voltage-dependent sodium currents. It should be noted that we cannot be certain that the recorded purinergic currents are purely mediated by homomeric P2X3 receptors since it has been reported that neuropathic DRG neurons show increased expression of P2X2/3 heteromeric receptors \[[@B10]\], thus we will simply describe purinergic currents as P2X responses.

![**Hyperexcitability of neuropathic DRG neurons to P2X activation and reversal by TTX**. Representative traces of P2X current responses induced by 10 μM α,β-meATP and recorded from cultured rat DRG neurons. (A) Recordings in control (naïve) neurons (B) in neuropathic SNL neurons, and (C) in neuropathic SNL neurons in the presence of 1 μM TTX. (D) Current densities of peak P2X responses from naïve and neuropathic DRG neurons, in absence and presence of 1 μM TTX (N = 6-17, \*\*\* *p*\< 0.0005).](1744-8069-7-14-1){#F1}

To examine more directly how P2X receptor activation influences the electroresponsiveness of neuropathic DRG neurons, we conducted current-clamp recordings under resting conditions with no current injection, then stimulated the DRG neurons with an application of 100 nM, 1 μM or 10 μM α,β-meATP. In naïve DRG neurons, α,β-meATP elicited dose-dependent cellular depolarizations. However, these responses were generally not sufficient to trigger neuronal firing (Figure [2A](#F2){ref-type="fig"}). None of the naïve neurons tested at 100 nM α,β-meATP generated action potentials, and 1 μM or 10 μM α,β-meATP applications induced action potentials in about 7% of naïve DRG neurons. In contrast, a greater proportion of neuropathic DRG neurons fired action potentials in response to P2X stimulation. For example, 100 nM α,β-meATP induced neuronal firing in about 29% of DRG neurons, 1 μM α,β-meATP induced 77% of neurons to fire, and all neuropathic neurons generated action potentials in response to 10 μM α,β-meATP (Figure [2B](#F2){ref-type="fig"}; N = 8-15 for each concentration in each group).

![**P2X activation triggers action potentials in neuropathic DRG neurons**. (A) Representative traces obtained in current clamp recordings at resting membrane potential (no current injection), and action potentials induced by the application of increasing concentrations of α,β-meATP. (B) Percentage of naïve and neuropathic DRG neurons that generated action potentials in response to increasing concentrations of α,β-meATP. (N = 8-15, all cells were pooled).](1744-8069-7-14-2){#F2}

Hyperexcitability of Neuropathic DRGs is Sensitive to PKC
---------------------------------------------------------

To test the sensitivity of α,β-meATP-mediated current responses of both naïve and neuropathic DRG neurons to PKC modulation, we used the wide-spectrum protein kinase blocker staurosporine. In voltage clamp experiments, we found that the fast spike recorded in response to α,β-meATP in neuropathic neurons was inhibited by 500 nM staurosporine (Figure [3A](#F3){ref-type="fig"}). The current density of the response to 10 μM α,β-meATP was decreased by 76% (neuropathic: 115.41 ± 14.59 pA/pF; + staurosporine: 27.57 ± 7.42 pA/pF; N = 4-9; Figure [3A, B](#F3){ref-type="fig"}). Responses to α,β-meATP in naïve DRG neurons were not sensitive to staurosporine (Figure [3C, D](#F3){ref-type="fig"}), nor were the responses sensitive to pre-incubation with PKC activator PMA (data not shown). The α,β-meATP-evoked transient spike in neuropathic neurons was also significantly inhibited by calphostin C, a more selective inhibitor of PKC (Figure [3A, B](#F3){ref-type="fig"}; neuropathic: 115.14 ± 14.59 pA/pF; + calphostin C: 9.88 ± 2.07 pA/pF; N = 6-9).

![**Exaggerated α,β-meATP-evoked response after neuropathic injury is blunted by PKC inhibition**. (A) Sample traces of current responses to 10 μM α,β-meATP in presence of PKC inhibitors staurosporine (500 nM) and calphostin C (100 nM) in neuropathic DRG neurons under voltage-clamp settings. (B) Current density of peak responses to 10 μM α,β-meATP in presence of PKC inhibitors (N = 4-17, \*\* *p*\< 0.005 \*\*\* *p*\< 0.0005, compared to the neuropathic group). (C) Representative traces of 10 μM α,β-meATP-evoked P2X3 responses in naïve DRG neurons (left), and after pre-incubation with 500 nM staurosporine (right). (D) Current density of 10 μM α,β-meATP-evoked P2X responses with and without 500 nM staurosporine (N = 5, non significant difference).](1744-8069-7-14-3){#F3}

To ascertain how PKC affected the electroresponsiveness of naïve versus neuropathic DRG neurons to P2X receptor activation, we conducted current-clamp experiments to measure the effects of inhibiting PKC with 100 nM calphostin C on action potentials induced by 1 and 10 μM α,β-meATP. The difference in electroresponsiveness between naïve and neuropathic neurons was less robust when we stimulated them with 100 nM α,β-meATP, thus it was not included in this set of experiments. In neuropathic DRG neurons activated with 1 μM α,β-meATP, only 29% of the neurons fired action potentials when pre-exposed to calphostin C, compared to 77% in absence of the PKC blocker (Figure [4A, B](#F4){ref-type="fig"}). When the neurons were activated with 10 μM α,β-meATP, 86% of neuropathic DRG neurons pre-treated with calphostin C generated action potentials, compared to 100% of untreated neuropathic neurons (Figure [4A, B](#F4){ref-type="fig"}; N = 7-13 for each concentration in each group).

![**Inhibition of α,β-meATP-evoked action potentials by the PKC blocker calphostin C in neuropathic DRG neurons**. (A) Typical recordings obtained from current-clamp experiments in neuropathic DRG neurons at resting membrane potential show action potentials generated in response to 1 and 10 μM α,β-meATP (upper panel), and their inhibition in the presence of 100 nM calphostin C (lower panel). (B) Percentage of DRG neurons that generated action potentials in response to α,β-meATP, in absence and presence of 100 nM calphostin C (N = 7-13).](1744-8069-7-14-4){#F4}

Neuropathic Injury-Induced Changes in Function and Expression of Voltage-Gated Sodium Channels
----------------------------------------------------------------------------------------------

To investigate the role of VGSCs in the hyperexcitable responses of neuropathic DRG neurons to α,β-meATP-evoked depolarization, we examined voltage-activated sodium currents in voltage-clamp experiments. We observed dramatically larger sodium current amplitudes in neuropathic VGSCs, compared to naïve controls, over a range of test potentials (Figure [5A](#F5){ref-type="fig"}). At the peak of the current-voltage relationship, the current density measured in neuropathic DRG neurons was 200% larger than in naïve neurons (Figure [5B](#F5){ref-type="fig"}). We also observed a significant leftward shift (-5 mV) in the voltage dependence of activation in neuropathic neurons (Figure [5C](#F5){ref-type="fig"}). Therefore both an increased current amplitude and a negative shift in voltage dependence of activation of VGSCs contribute to the hypersensitivity of neuropathic DRG neurons to purinergic stimulation.

![**Increased current amplitude and hyperpolarizing shift in voltage dependence of sensory sodium channels after neuropathic injury**. (A) Representative current-voltage relationship traces of VGSC currents recorded from naïve and neuropathic DRG neurons. (B) Analysis of peak current amplitudes of voltage-gated sodium currents recorded at V~max~in naïve and neuropathic conditions (N = 4-5 for both groups, \*\* *p*\< 0.005). (C) Sodium channel conductance was fitted with the Boltzman function (see Materials and Methods) from voltage-gated currents recorded in naïve and neuropathic neurons (N = 4-5).](1744-8069-7-14-5){#F5}

To investigate expression changes in VGSC, we performed in situ hybridization (ISH) experiments to examine alterations of mRNA levels in DRG tissue following SNL injury. We probed the expression of the Na~v~1.3 gene based on reports that this VGSC subunit increases significantly after SNL injury (see discussion) and axotomy \[[@B12]\]. Na~v~1.3 mRNA expression was qualitatively assessed in DRG sections from naïve, sham-operated and SNL-injured adult rats. In both naïve and sham-operated rats, very weak Na~v~1.3 mRNA expression was detected over a subset of small-, medium- and large-diameter neurons as identified using light microscopy (data not shown). In contrast, unilateral ligation of L5 and L6 spinal nerves resulted in robust upregulation of Na~v~1.3 mRNA expression within the corresponding ipsilateral DRGs (Figure [6A, B](#F6){ref-type="fig"}). The increased level of Na~v~1.3 mRNA expression was detected as early as 2 days post-injury, and remained upregulated at all time points examined in small-, medium- and large-diameter neurons. No changes were detected in the intact L4 DRG, or in contralateral L5 and L6 DRGs from SNL injured rats.

![**Increased expression of Na~v~1.3 mRNA in DRG neurons following SNL injury**. (A) Autoradiographic in situ hybridization data showing increased levels of Na~v~1.3 mRNA in rat DRG neurons from 2 to 42 days after neuropathic injury. Arrows indicate the lumbar DRG level ipsilateral to the SNL injury. Note that the increase in Na~v~1.3 mRNA occurs in the ipsilateral (injured) L5 and L6 DRGs, but remains unchanged in (uninjured) L4 DRG and sham DRGs. Sham DRGs represent the 14 day post-injury time point. (B) High magnification (40×) images of emulsion-dipped sections showing increased Na~v~1.3 mRNA expression in cell bodies of small diameter DRG neurons (arrows) on the ipsilateral side of the nerve injury. Scale bar, 50 μm.](1744-8069-7-14-6){#F6}

PKC Modulation of Na~v~1.3 Currents
-----------------------------------

As we did not observe any modulatory role of PKC on the function of endogenous P2X3 receptors in DRG neurons (Figure [3C, D](#F3){ref-type="fig"}), it is unlikely that PKC is modulating neuronal excitability by altering P2X3 function. A more likely mechanism for the effects of PKC on the excitability of neuropathic DRG neurons is a modulation of the activity of Na~v~1.3 channels. Because native DRG neurons express a wide range of VGSC subtypes, and since no pharmacological tools are available to isolate the Na~v~1.3 activity, we tested this hypothesis in voltage-clamp experiments on a CHO cell line stably expressing the Na~v~1.3 subunit \[[@B20]\]. These cells displayed robust and reproducible voltage-gated sodium currents (Figure [7A](#F7){ref-type="fig"}). After treatment with the PKC blocker calphostin C, the voltage-dependence of Na~v~1.3 activity was shifted by 10 mV in the depolarizing direction (Figure [7B](#F7){ref-type="fig"}). PKC inhibition also significantly reduced the amplitude of Na~v~1.3 currents (Figure [7C](#F7){ref-type="fig"}). The current density at peak activation was reduced by 46% by calphostin C (control: 335.46 ± 79.41 pA/pF; + calphostin C: 179.70 ± 23.53 pA/pF; N = 6-8).

![**Na~v~1.3 activity is positively regulated by PKC**. (A) Membrane potential depolarization induced Na~v~1.3-mediated sodium currents in Na~v~1.3-transfected CHO cells evoked using stimulus protocol described in methods section. (B) Current-voltage relationship of Na~v~1.3 activity in the presence and absence of 100 nM calphostin C (N = 6-8). (C) Voltage-dependent current density mediated by Na~v~1.3 channels in CHO cells in the presence and absence of 100 nM calphostin C (N = 6-8).](1744-8069-7-14-7){#F7}

Discussion
==========

The present study suggests that activation of P2X receptors elicits excessive firing in neuropathic DRG neurons indirectly, through activation of upregulated Na~v~1.3 sodium channels. We also show that VGSC-mediated hyperexcitability is modulated by PKC.

Activation of P2X Receptors Elicits Ectopic Action Potentials
-------------------------------------------------------------

Neuropathic injury models such as SNL induce a wide array of changes in the physiology of DRG neurons. Although SNL neurons display excessive firing of action potentials in response to P2X activation, we cannot conclude that the ability to trigger hypersensitive responses is exclusive to P2X receptors. Indeed, we also observed similar abnormal action potential firing in a small number of neuropathic cells stimulated with the TRPV1 agonist capsaicin (data not shown). We did not observe any significant changes in the current amplitude of P2X receptors in neuropathic DRG neurons treated with a saturating concentration of TTX. This is in accordance to another study of P2X receptor activity in injured sensory neurons, where it was reported that the amplitude of α,β-meATP-evoked currents in neuropathic small diameter DRG neurons did not significantly differ from those recorded from naïve neurons \[[@B10]\]. These observations are consistent with the idea that neuropathic neurons are generally hyper-responsive to depolarizing stimuli because of their intrinsic, voltage-dependent hyperexcitability. P2X3 receptors are fast-desensitizing while other receptor-channels such as TRPV1 have slower kinetics of activation and desensitization \[[@B21]\]. Thus, ligand-gated cation channels with different kinetics may elicit specific patterns and/or durations of ectopic action potential firing.

PKC Modulation of Neuronal Hyperexcitability
--------------------------------------------

The involvement of PKC in neuropathic pain has been well demonstrated \[[@B22]\], and certain isoforms of PKC are high value targets for pain therapeutics \[[@B23]\]. However, the mechanism by which PKC regulates neuronal excitability remains elusive. The function of several sensory receptor-channels has been shown to be modulated by PKC, such as TRPV1 \[[@B24]\], P2X2/3 \[[@B25]\], and ASICs \[[@B26]\]. In agreement with reports demonstrating the role of protein kinases in neuropathic pain mechanisms \[[@B17],[@B27],[@B28]\], we show that sensitization to ATP of neuropathic neurons can be inhibited by the wide-spectrum protein kinase blocker staurosporine, as well as calphostin C, a more selective PKC inhibitor \[[@B29]\] shown to be effective against PKC isoforms involved in neuropathic pain \[[@B30]\].

We did not observe any effect of staurosporine or the PKC activator PMA on P2X3 responses to α,β-meATP in either naïve DRG neurons or HEK293 cells expressing homomeric P2X3 receptors (data not shown), which strongly suggests that PKC is not contributing to hyperexcitability through a direct modulation of P2X receptors in neuropathic DRG neurons. Our voltage-clamp recordings conducted in the presence of PKC inhibitors showed a decrease in the fast spike component of the inward current, corresponding to a reduction in voltage-gated sodium current, while the remaining P2X component was relatively unchanged. The modulation of sodium channel activity by calphostin C was also observed in our current-clamp experiments where we demonstrated that PKC inhibition attenuates the generation of action potentials in neuropathic neurons. In line with evidence demonstrating modulation of VGSCs by PKC \[[@B14]-[@B16],[@B31]-[@B33]\], our results point to a major role for PKC-modulated VGSCs in the hypersensitivity of neuropathic DRG neurons to purinergic stimulation.

Upregulation of Na~v~1.3 Sodium Channels Expression and Activity
----------------------------------------------------------------

In order to verify that PKC is regulating hyperexcitability through modulation of VGSC, we first needed to identify which VGSC α subunit is up-regulated in neuropathic DRG neurons. From our characterization of the changes to the VGSC profile following SNL, the increase in current amplitude and the hyperpolarizing shift in voltage-dependence observed in neuropathic neurons are likely caused by increased expression of Na~v~1.3. This is consistent with reports showing an increase in the expression of embryonic Na~v~1.3 α subunit expression in DRG neurons after axotomy \[[@B12]\] and SNL injury \[[@B34],[@B35]\]. We cannot exclude possible changes in the function of other VGSC subunits, such as Na~v~1.7 and Na~v~1.8, which may contribute to neuropathic hyperexcitability; however, their expression levels have been shown to decrease after neuropathic injury \[[@B36],[@B37]\]. Under normal conditions, Na~v~1.8 is the main generator of action potentials in small diameter DRG neurons. With respect to activation, Na~v~1.8 has a V~0.5~of -16 to -21 mV, whereas for Na~v~1.3 the V~0.5~is -23 mV \[[@B38]\]. The difference in voltage-dependence of the two Na~v~subunits corresponds to the difference in voltage-dependence that we observed between neuropathic and naïve DRG neurons, suggesting that Na~v~1.3 is a major contributor to the VGSC-mediated currents in neuropathic neurons.

Increased expression of the Na~v~1.3 α subunit following SNL injury was confirmed through our ISH data. The increased expression level was confined to the injured L5 and L6 DRGs and remained unaltered on the contralateral (uninjured) DRGs. Changes in expression of VGSC subunit mRNA have been reported in both rodents and humans \[[@B12],[@B34],[@B37]\]. An increase in expression of Na~v~1.3 has been observed in trigeminal neuralgia patients \[[@B37]\], suggesting a role for Na~v~1.3 modulation in pathological pain. Neuronal VGSCs are heteromeric complexes containing α subunits associated with β subunits. These auxiliary subunits have been shown to modulate the function of various α subunits \[[@B39]\]. Of the three β subunits identified so far, the most relevant here is the β3 subunit because of its co-localization with Na~v~1.3 in small diameter DRG neurons. Furthermore, the expression of both proteins increases after neuropathic injury within the same population of neurons \[[@B12],[@B40]\]. However, the modulatory effects of the β3 subunit on the Na~v~1.3 subunit are not clear. Some have reported a depolarizing shift in the voltage-dependence of activation and inactivation of Na~v~1.3 \[[@B41],[@B42]\], others reported no change in voltage-dependence of activation, but did observe a decrease in the rate of recovery from inactivation \[[@B20]\]. Unlike other α subunits, the current density of Na~v~1.3 does not seem to be affected by the presence of β subunits \[[@B20],[@B40]\]. In any case, the potential modulation of Na~v~1.3 by the auxiliary β3 subunit does not fit with the changes in the function of Na~v~1.3 after neuropathic injury that we are reporting here. However, because all these studies were based on the use of transfected cell lines, the exact role of native β3 subunits in sensory neurons is still unknown so they could possibly facilitate neuronal hyperexcitability. While some observed that treatment with antisense oligodeoxynucleotides targeting Na~v~1.3 reversed changes in pain responses associated with nerve injury \[[@B43],[@B44]\], others reported that decreasing expression of Na~v~1.3 was not sufficient to attenuate neuropathic pain behaviours \[[@B45],[@B46]\]. There is currently no consensus on the involvement of Na~v~1.3 function in mediating neuropathic pain. Therefore, until a selective blocker is available for clinical evaluation, its contribution to pain pathology will remain unclear.

PKC Regulates Na~v~1.3 Activity
-------------------------------

After identifying Na~v~1.3 as the VGSC α subunit predominantly responsible for the hyperexcitability following neuropathic injury, we examined the PKC modulation of its function isolated in a heterologous system. From currents recorded from CHO- Na~v~1.3 cells, it was clear that PKC enhances the function of Na~v~1.3 by increasing its activity at more hyperpolarizing potentials and by increasing its current amplitude, a combination that could dramatically boost the sensitivity of DRG nociceptors to a range of depolarizing stimuli. Several VGSC isoforms have been shown to be modulated by PKC \[[@B15],[@B16],[@B32]\], but we report here for the first time the positive regulation of Na~v~1.3 function by PKC in native as well as recombinant cell preparations. The molecular mechanisms of this modulation require further investigation to know if Na~v~1.3 is directly phosphorylated by PKC such as the Na~v~1.8 subunit \[[@B47]\]. In any case, the identification of phosphorylated domain(s) in the Na~v~1.3 subunit or associated proteins could provide valuable information for the design of novel neuropathic pain therapeutics.

Conclusions
===========

The present study shows that injury-induced hyper-responsiveness of DRG neurons to P2X activation is mediated by increased expression of Na~v~1.3 sodium channel subunit, and not due to any significant change in the function of P2X receptors. We also provide evidence for the first time that Na~v~1.3-mediated hyperexcitability can be modulated by PKC, which directly regulates the activity of Na~v~1.3 channels. This study emphasizes the importance of VGSCs in injury-induced increases in excitability to algogenic mediators, and provides new insights into functional regulation of Na~v~1.3 in injured peripheral neurons.
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